In late August, the U.S. Department of Health and Human Services (HHS) signaled a major policy change regarding marijuana. HHS announced its recommendation to alter the classification of marijuana from a Schedule I to a Schedule III controlled substance, under the Controlled Substances Act. This development, of course, carries potential sweeping implications for the tax and banking aspects of the burgeoning marijuana industry in the United States.
According to More with McGlinchey episode 61, significant voices leading the discussion on these implications include corporate cannabis attorney Daniel Shortt, tax attorney Douglas Charnas, and financial services regulatory attorney Aaron Kouhoupt. Their analysis sheds light on how this policy change could specifically affect state legal, medical, and adult-use marijuana programs.
The classification of marijuana in the Controlled Substances Act has long been a point of contention. Its placement in Schedule I – the category reserved for substances with a high potential for abuse and no currently accepted medical use – has long been a barrier for businesses involved with marijuana. From facing challenges banking their profits to being unable to claim federal tax deductions, the legal marijuana industry has been significantly restrained.
Moving marijuana to Schedule III, a category for substances with moderate to low potential for physical and psychological dependence, could signal a sea change for the industry. While this step obviously can’t eliminate all the regulatory challenges faced by the marijuana industry, the potential to change its banking and tax situation can’t be understated.
As analyzed in the More with McGlinchey podcast, Douglas Charnas and Aaron Kouhoupt delve into what this change could mean for the marijuana industry. They highlight the ongoing need to watch how regulation and policy shifts could impact not only marijuana businesses but also their relationship with the banking sector and federal agencies.
While it’s critical to remember that HHS’s recommendation is just that – a recommendation – it carries a potential look into the future of an industry currently in legal flux. It is important for any stakeholders in the industry to stay abreast of these potential changes and their subsequent effects on the industry’s landscape.